Nova Mentis (OTC: NMLSF) Completes Production of Psilocybin Microdose Capsules
Company Plans to Submit Clinical Trial Application in Canada Vancouver, British Columbia— September 15, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader […]